 This study found that hematuria in patients with IJN was not associated with active pathological lesions or worse outcomes. Additionally, the authors concluded that lower EGFR was an independent risk factor for progression. This article was authored by Chihiro Iwasaki, Takahito Moriyama, K. Tanaka, and others.